MDxHealth SA (MDXH)
(Delayed Data from NSDQ)
$2.67 USD
+0.17 (6.80%)
Updated May 1, 2024 04:00 PM ET
After-Market: $2.69 +0.02 (0.75%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth D Momentum D VGM
Income Statements
Fiscal Year end for MDxHealth SA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 70 | 37 | 22 | 18 | 12 |
Cost Of Goods | NA | 18 | 12 | 10 | 12 |
Gross Profit | NA | 19 | 11 | 8 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 57 | 37 | 35 | 43 |
Income After Depreciation & Amortization | 0 | -38 | -27 | -27 | -43 |
Non-Operating Income | NA | 0 | 0 | 0 | 0 |
Interest Expense | NA | 6 | 2 | 2 | 1 |
Pretax Income | NA | -44 | -29 | -29 | -44 |
Income Taxes | NA | 0 | 0 | 0 | -1 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -43 | -44 | -29 | -29 | -43 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -43 | -44 | -29 | -29 | -43 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -33 | -24 | -24 | -40 |
Depreciation & Amortization (Cash Flow) | NA | 5 | 3 | 3 | 3 |
Income After Depreciation & Amortization | 0 | -38 | -27 | -27 | -43 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 25.96 | NA | 12.08 | 8.43 | 6.25 |
Diluted EPS Before Non-Recurring Items | -1.66 | NA | -2.40 | -3.40 | -5.30 |
Diluted Net EPS (GAAP) | -1.66 | -2.80 | -2.40 | -3.40 | -6.90 |
Fiscal Year end for MDxHealth SA falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 19.40 | NA | NA | 14.70 |
Cost Of Goods | NA | NA | NA | NA | 5.99 |
Gross Profit | NA | NA | NA | NA | 8.72 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 17.44 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -8.72 |
Non-Operating Income | NA | NA | NA | NA | 0.00 |
Interest Expense | NA | NA | NA | NA | 2.99 |
Pretax Income | NA | NA | NA | NA | -11.71 |
Income Taxes | NA | NA | NA | NA | 0.00 |
Minority Interest | NA | NA | NA | NA | 0.00 |
Investment Gains/Losses | NA | NA | NA | NA | 0.00 |
Other Income/Charges | NA | NA | NA | NA | 0.00 |
Income From Cont. Operations | NA | -10.72 | NA | NA | -11.71 |
Extras & Discontinued Operations | NA | 0.00 | NA | NA | 0.00 |
Net Income (GAAP) | NA | -10.72 | NA | NA | -11.71 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 27.49 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | -0.39 | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | -0.39 | NA | NA | -0.50 |